Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Emtnester...........

Mar 17, 2009 01:16PM
1
Mar 17, 2009 01:27PM

OK. So you've basically answered my question and dispelled the notion that the "Final Rejection" could pertain to specific claims but not the whole patent. As you say, we've been hit with the Big Stick. I'm bothered by this simply because my position through this entire process was the need for the company to remain silent about anything regarding the USPTO process. As of late, they seemed to be a little more confident. I know everyones looking for a silver lining but, I really believe the lack of licensing activity may have just justified itself. This is a lesson to those prognosticators who would speculate on matters that we clearly have no control. The courts, USPTO and licensees for that matter, are all independent parts that certainly don't dictate to one another on the issues of validity or obviousness. Each one has the right to make their own decision. Unfortunately the USPTO's decision is the most important. Until tomorrow......GLTA.

2
Mar 17, 2009 04:09PM
4
Mar 17, 2009 05:22PM
Share
New Message
Please login to post a reply